DTIL - Company ID 0001357874
The table below shows PRECISION BIOSCIENCES INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $34.26M | $68.70M | $48.73M | $25.10M | $115.53M | $24.29M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $54.17M | $59.56M | $53.38M | $46.12M | $115.24M | $98.06M |
| SG&A |
PRECISION BIOSCIENCES INC reported annual revenue of $34.26M for fiscal year 2025. That is down 50.1% from $68.70M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $10.88M (FY 2018) to $34.26M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $32.24M |
| $35.30M |
| $39.09M |
| $41.28M |
| $39.67M |
| $36.05M |
| Operating income | -$52.15M | -$26.16M | -$43.74M | -$62.31M | -$39.38M | -$109.83M |
| Income tax | $0.00 | $0.00 | - | - | - | $23.00K |
| Net income | -$45.72M | $7.17M | -$61.32M | -$111.64M | -$30.60M | -$109.01M |
| EPS (diluted) | -$3.56 | $1.04 | -$15.96 | -$38.10 | -$0.52 | - |